Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from China Isotope & Radiation Corp. ( (HK:1763) ) is now available.
China Isotope & Radiation Corporation announced the results of its Extraordinary General Meeting (EGM) held on July 25, 2025, where the appointment of Mr. Xiao Yafei as an executive director was approved. Mr. Xiao was also appointed as the chairman of the board and several board committees, indicating a strategic leadership shift aimed at strengthening the company’s governance and innovation capabilities.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on the production and distribution of isotopes and radiation-related products. The company primarily serves the medical, industrial, and scientific sectors, providing essential materials and services for various applications.
Average Trading Volume: 510,819
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.12B
For an in-depth examination of 1763 stock, go to TipRanks’ Overview page.